United States · Series F startup

Who invested in Capital Rx

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcareHealthtechPharma

Funding summaryUpdated 5 Nov 2026

$264Mraised across 2 rounds since 2019, from 2 sources

$12MRound$252MSeries F
Latest round
Series F, $252MSept 2025
Led by
General Catalyst and Wellington Management
Step-upi
21×
Investors
3 (2 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202020212022202320242025
$12MRound$252MSeries F
First round
Round, $12M
Jul 2019
Biggest round
$252M
Series F · Sept 2025
Between rounds
6.2 years
from the last two

The rounds

  1. Sept 2025
    Series F$252M2 new

    Reported by AlleyWatchSEC filing: $231M sold, first sale Aug 2025

  2. Jul 2019
    Round$12M1 new

    Reported by FinSMEsSEC filing: $12M sold, first sale Jul 2019

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

General CatalystVC firm1round, led 1
Wellington ManagementVC firm1round, led 1
Edison PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Capital Rx

Who invested in Capital Rx?

Capital Rx's investors include General Catalyst, Wellington Management and Edison Partners. General Catalyst led its latest round.

How much has Capital Rx raised?

Capital Rx has raised $264M across 2 rounds since 2019.

When did Capital Rx last raise?

Capital Rx's most recent round was a Series F of $252M in Sept 2025, led by General Catalyst.

What was Capital Rx's biggest round?

Its most recent round, $252M in Sept 2025, is also its largest on record.

Who backed Capital Rx first?

Capital Rx's first round on record, in Jul 2019, was backed by Edison Partners.

What stage is Capital Rx at?

Capital Rx's latest named round is a Series F, in Sept 2025.

Where is Capital Rx based?

Capital Rx is based in the United States.

Who led Capital Rx's rounds?

General Catalyst led the Series F in 2025.

Companies like Capital Rx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.